Analysts Optimistic On Aurobindo After Strong Earnings

 
• By Penelope MacRae

Analysts are enthusiastic about the US earnings prospects of leading Indian generic firm Aurobindo after the company reported a nearly 20% jump in consolidated net profit for the third quarter, and declared it would focus on digesting its acquisitions.

Steps
Aurobindo reported strong earnings growth in the third quarter • Source: Shutterstock

More from Business

More from Generics Bulletin